Marginum is pioneering fluorescence-based optical tissue monitoring technologies for oncological surgery. Its data-driven solutions enable safe and efficient monitoring of tumour tissues during cancer surgery without compromising pre-existing surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure the seamless clinical compatibility of its technological solutions.
| Website | https://www.marginum.com/ |
| Employees | 11 (7 on RocketReach) |
| Founded | 2020 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Medical Technology, Fluorescence Imaging, Cancer Surgery, Tumor Detection, Surgical Guidance, Oncology Technology, Biosensors, Medical Devices, Data Driven Healthcare, Precision Oncology, Minimally Invasive Surgery, Cancer Diagnostics, Surgical Navigation, Healthcare Technology, Medical Imaging, Biomedical Engineering, Optics Technology, Real Time Imaging, Tissue Analysis |
| Competitors | Google, Adobe, Amplitude, Optimizely, FullStory, VWO, Kameleoon, Crazy Egg, Convert.com, SiteSpect, Inc. +36 more (view full list) |
Looking for a particular Marginum employee's phone or email?
Samu Lehtonen is the CEO and Co-Founder of Marginum.
7 people are employed at Marginum.